Considering the elevation of PAX6 during the AD process and its strong inhibition effect on IDH3β transcription, we next aim to test whether downregulating PAX6 could also alleviate AD pathology in 5xFAD mice. The gene discussed is IDH3B; the disease is Alzheimer disease.